Precision NanoSystems Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Precision NanoSystems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10646
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Precision NanoSystems Inc (Precision NanoSystems) is a biopharmaceutical company that provides nanotechnology solutions to manufacture nanoparticles for molecular understanding and treatment of disease. The company offers products which include nanosystems, transfection kits for primary cells and nucleic acids, and formulation solutions. Its proprietary NanoAssemblr platform enables the rapid and controlled manufacture of nanomedicines such as liposomes, lipid nanoparticles, polymeric nanoparticles. Precision NanoSystems also provides Neuro9 transfection kit for the study of gene function in neurons and glia cells. The company offers nanosystems, instruments, reagents, and services to life sciences researchers through a network of distributors across the US and Canada. Precision NanoSystems is headquartered in Vancouver, British Columbia, Canada.

Precision NanoSystems Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Precision NanoSystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Precision NanoSystems Inc, Medical Devices Deals, 2012 to YTD 2018 9
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Precision NanoSystems Raises USD6 Million in Series B Venture Financing 11
Precision NanoSystems Raises USD13.4 Million in Series A Venture Financing 12
Precision NanoSystems Raises Funds through Venture Financing 13
Partnerships 14
Precision NanoSystems Enters Into Agreement with Arcturus Therapeutics 14
Precision NanoSystems Inc – Key Competitors 15
Precision NanoSystems Inc – Key Employees 16
Precision NanoSystems Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Jul 19, 2018: Precision NanoSystems: 2018 Shaping the Future of Nanomedicine symposium 18
Product News 19
Mar 08, 2017: Precision NanoSystems unveils innovative system for scale-up manufacture of nanomedicines 19
Other Significant Developments 20
Jan 24, 2018: Precision NanoSystems Technology Included in Newly Opened Non-Coding RNA Precision Diagnostics and Therapeutics Core Facility 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Key Facts 2
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Precision NanoSystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Precision NanoSystems Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Precision NanoSystems Inc, Medical Devices Deals, 2012 to YTD 2018 9
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Precision NanoSystems Raises USD6 Million in Series B Venture Financing 11
Precision NanoSystems Raises USD13.4 Million in Series A Venture Financing 12
Precision NanoSystems Raises Funds through Venture Financing 13
Precision NanoSystems Enters Into Agreement with Arcturus Therapeutics 14
Precision NanoSystems Inc, Key Competitors 15
Precision NanoSystems Inc, Key Employees 16

List of Figures
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Precision NanoSystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Precision NanoSystems Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Precision NanoSystems Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hunt Oil Co:企業の戦略的SWOT分析
    Hunt Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • BPER Banca Spa:企業のM&A・事業提携・投資動向
    BPER Banca Spa - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BPER Banca Spa Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • ATLAS Oil Company:石油・ガス:M&Aディール及び事業提携情報
    Summary ATLAS Oil Company (ATLAS) is an oil and gas company that offers fuel supply and logistic services. The company’s services comprise supply, renewable fuels, bulk fueling, fuel on demand, logistics, fixed price contracts, frac site fueling, emergency refuel, crude hauling, transloading and on- …
  • Bausch & Lomb Incorporated:企業のM&A・事業提携・投資動向
    Bausch & Lomb Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bausch & Lomb Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Bioactive Bone Substitutes Ltd:製品パイプライン分析
    Summary Bioactive Bone Substitutes Ltd (BBS) is a manufacturer of biologically active medical device implants for orthopedic surgery. The company offers technology platforms, artebone, research and development, and patents. Its artebone is made up of an animal source of bone material used for bone r …
  • Eneco Holding NV-エネルギー分野:企業M&A・提携分析
    Summary Eneco Holding N.V. (Eneco) is an integrated energy company. It produces, trades, transmits and supplies gas, electricity and heat. Eneco undertakes the sale, rental, installation, and maintenance of heating and hot water equipment; and maintenance of the electricity, gas and district heat ne …
  • North Pacific Bank,Ltd:企業の戦略・SWOT・財務情報
    North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report Summary North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Atlantia SpA (ATL):企業の財務・戦略的SWOT分析
    Atlantia SpA (ATL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • TDK Corporation (6762):企業の財務・戦略的SWOT分析
    TDK Corporation (6762) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Christian Dior SE:企業の戦略・SWOT・財務情報
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Safe Orthopaedics SA (SAFOR):企業の財務・戦略的SWOT分析
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • Webjet Limited:企業の戦略・SWOT・財務情報
    Webjet Limited - Strategy, SWOT and Corporate Finance Report Summary Webjet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • PT Pembangkitan Jawa-Bali:電力:M&Aディール及び事業提携情報
    Summary PT Pembangkitan Jawa-Bali (PJB), a subsidiary of PT PLN (Persero), generates and supplies electricity. It is responsible to meet the electricity requirements of the Java-Madura-Bali (JAMALI) electric system. The company generates electricity from energy sources such as oil, natural gas, coal …
  • Meiji Co Ltd:企業の戦略・SWOT・財務分析
    Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Nimir Industrial Chemical Ltd (NICL):企業の財務・戦略的SWOT分析
    Summary Nimir Industrial Chemical Ltd (NICL) is a chemical company that manufactures and distributes oleo chemicals and chlor alkali. The company offers products such as stearic acid, soap noodles, glycerin, caustic soda, sodium hypochlorite, and hydrochloric acid, among others. It also provides raw …
  • SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary SuanFarma SA (SuanFarma Group) is a drug development company that offers production, development, and marketing of raw materials and finished dosage forms. The company’s products portfolio includes amoxiciline capsules, enalapril tablets, colistin methanesulphonate, azitromicine film coated …
  • Genedata AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Astron Corp Ltd (ATR):企業の財務・戦略的SWOT分析
    Astron Corp Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Barrick Gold Corp:企業の戦略・SWOT・財務情報
    Barrick Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Barrick Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆